Scientists seek simpler tests for muscular dystrophy
NCT ID NCT05019625
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aims to find less invasive ways to measure muscle disease activity in people with muscular dystrophies. Instead of painful muscle biopsies, researchers will use blood and urine samples along with painless ultrasound and electrical tests on the arms and legs. The goal is to develop better tools to track disease severity and response to future treatments.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BECKER MUSCULAR DYSTROPHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Boston Children's Hospital
ACTIVE_NOT_RECRUITINGBoston, Massachusetts, 02115, United States
-
Brigham and Women's Hospital
RECRUITINGBoston, Massachusetts, 02115, United States
-
Massachusetts General Hospital
RECRUITINGBoston, Massachusetts, 02129, United States
-
University of Pittsburgh
RECRUITINGPittsburgh, Pennsylvania, 15213, United States
-
Wake Forest University
RECRUITINGWinston-Salem, North Carolina, 27157, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a lower steroid dose preserve strength in young boys with DMD?
- Can we measure the progression of childhood myotonic dystrophy well enough to test new therapies?
- Can MRI reveal the hidden progression of muscular dystrophy?
- Can brain scans unlock hidden effects of becker muscular dystrophy?
- Can a targeted infusion slow muscle decline in duchenne? a new trial aims to find out.
- Can a massive patient database unlock new treatments for muscular dystrophy?